New Pfizer data shows promise for preventing infections with no symptoms

Published



New data on the Pfizer-BioNTech coronavirus vaccine, gathered by Israel’s Ministry of Health, revealed promising signs in preventing the transmission of COVID-19 without symptoms.

The latest analysis, published on Thursday, found that after two weeks from receiving the second dose of the vaccine, it is 97% effective in preventing symptomatic COVID-19 cases and is 94% effective against infection without symptoms.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.